Description
Carzomib 60mg Injection is a targeted therapy medication used in the treatment of multiple myeloma, a type of blood cancer. Its active ingredient is Carfilzomib, a proteasome inhibitor. Carfilzomib works by blocking the action of proteasomes, which are protein complexes within cells that break down unwanted or damaged proteins. In cancer cells, particularly multiple myeloma cells, these proteasomes play a crucial role in their survival and proliferation. By inhibiting proteasomes, Carzomib leads to the accumulation of abnormal proteins within the cancer cells, triggering cell death. It is typically administered intravenously by a healthcare professional. Common side effects may include fatigue, shortness of breath, nausea, diarrhea, fever, and changes in blood cell counts. It is important to discuss potential side effects and contraindications with your doctor. Carzomib 60mg Injection should be stored at room temperature, protected from light, and kept out of reach of children.
